Metropolitan Life Insurance Company (MetLife)’s Abercrombie & Fitch ANF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,567
| Closed | -$322K | – | 140 |
|
|
2024
Q1 | $322K | Sell |
2,567
-205
| -7% | -$23.4K | 0.01% | 570 |
|
|
2023
Q4 | $245K | Sell |
2,772
-140
| -5% | -$9.96K | 0.01% | 652 |
|
|
2023
Q3 | $164K | Buy |
2,912
+313
| +12% | +$13.9K | 0.01% | 769 |
|
|
2023
Q2 | $97.9K | Sell |
2,599
-175
| -6% | -$4.99K | ﹤0.01% | 1028 |
|
|
2023
Q1 | $77K | Sell |
2,774
-304
| -10% | -$8.46K | ﹤0.01% | 1146 |
|
|
2022
Q4 | $70.5K | Buy |
3,078
+511
| +20% | +$10.1K | ﹤0.01% | 1258 |
|
|
2022
Q3 | $39.9K | Sell |
2,567
-764
| -23% | -$13.2K | ﹤0.01% | 1605 |
|
|
2022
Q2 | $56.4K | Hold |
3,331
| – | – | ﹤0.01% | 1428 |
|
|
2022
Q1 | $107K | Sell |
3,331
-11,625
| -78% | -$403K | ﹤0.01% | 1153 |
|
|
2021
Q4 | $521K | Sell |
14,956
-2,055
| -12% | -$80.3K | 0.01% | 1393 |
|
|
2021
Q3 | $640K | Hold |
17,011
| – | – | 0.01% | 1286 |
|
|
2021
Q2 | $790K | Sell |
17,011
-805
| -5% | -$32.4K | 0.01% | 1186 |
|
|
2021
Q1 | $611K | Sell |
17,816
-684
| -4% | -$18.9K | 0.01% | 1299 |
|
|
2020
Q4 | $377K | Hold |
18,500
| – | – | 0.01% | 1552 |
|
|
2020
Q3 | $258K | Sell |
18,500
-1,226
| -6% | -$14.3K | ﹤0.01% | 1623 |
|
|
2020
Q2 | $210K | Hold |
19,726
| – | – | ﹤0.01% | 1758 |
|
|
2020
Q1 | $179K | Hold |
19,726
| – | – | ﹤0.01% | 1656 |
|
|
2019
Q4 | $341K | Sell |
19,726
-857
| -4% | -$14.2K | 0.01% | 1558 |
|
|
2019
Q3 | $321K | Buy |
20,583
+106
| +0.5% | +$1.77K | 0.01% | 1568 |
|
|
2019
Q2 | $328K | Hold |
20,477
| – | – | 0.01% | 1562 |
|
|
2019
Q1 | $561K | Hold |
20,477
| – | – | 0.01% | 1227 |
|
|
2018
Q4 | $411K | Sell |
20,477
-2,549
| -11% | -$47.7K | 0.01% | 1321 |
|
|
2018
Q3 | $486K | Hold |
23,026
| – | – | 0.01% | 1368 |
|
|
2018
Q2 | $564K | Hold |
23,026
| – | – | 0.01% | 1232 |
|
|
2018
Q1 | $557K | Buy |
23,026
+1,202
| +6% | +$25.4K | 0.01% | 1204 |
|
|
2017
Q4 | $380K | Sell |
21,824
-25,368
| -54% | -$385K | 0.01% | 1464 |
|
|
2017
Q3 | $681K | Sell |
47,192
-212
| -0.4% | -$2.42K | ﹤0.01% | 1480 |
|
|
2017
Q2 | $590K | Hold |
47,404
| – | – | ﹤0.01% | 1564 |
|
|
2017
Q1 | $566K | Buy |
47,404
+1,589
| +3% | +$18.9K | ﹤0.01% | 1565 |
|
|
2016
Q4 | $550K | Sell |
45,815
-63,705
| -58% | -$946K | ﹤0.01% | 1669 |
|
|
2016
Q3 | $1.74M | Sell |
109,520
-13
| -0% | -$251 | 0.01% | 1004 |
|
|
2016
Q2 | $1.95M | Buy |
109,533
+1,260
| +1% | +$30K | 0.01% | 944 |
|
|
2016
Q1 | $3.42M | Buy |
108,273
+2,191
| +2% | +$61.5K | 0.03% | 690 |
|
|
2015
Q4 | $2.86M | Sell |
106,082
-1,761
| -2% | -$40.9K | 0.02% | 754 |
|
|
2015
Q3 | $2.29M | Sell |
107,843
-1,636
| -1% | -$33.3K | 0.02% | 859 |
|
|
2015
Q2 | $2.35M | Buy |
109,479
+47,828
| +78% | +$1.05M | 0.02% | 905 |
|
|
2015
Q1 | $1.36M | Buy |
61,651
+451
| +0.7% | +$11.1K | 0.01% | 1045 |
|
|
2014
Q4 | $1.75M | Buy |
61,200
+546
| +0.9% | +$16.8K | 0.01% | 1020 |
|
|
2014
Q3 | $2.2M | Sell |
60,654
-695
| -1% | -$28.3K | 0.02% | 915 |
|
|
2014
Q2 | $2.65M | Sell |
61,349
-2,873
| -4% | -$111K | 0.02% | 864 |
|
|
2014
Q1 | $2.47M | Buy |
64,222
+1,218
| +2% | +$44.5K | 0.02% | 870 |
|
|
2013
Q4 | $2.07M | Buy |
63,004
+14,287
| +29% | +$493K | 0.01% | 960 |
|
|
2013
Q3 | $1.72M | Sell |
48,717
-1,453
| -3% | -$64.3K | 0.01% | 1008 |
|
|
2013
Q2 | $2.27M | Buy |
+50,170
| New | +$2.47M | 0.02% | 818 |
|
Other funds holding ANF
Metropolitan Life Insurance Company (MetLife)'s ANF Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Abercrombie & Fitch (ANF) in Q2 2024, closing a stake of 2,567 shares — an estimated $322K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ANF in Q2 2013 and held it in 44 quarters. The position peaked at $3.42M in Q1 2016. 435 funds tracked by Wall St. Rank hold ANF as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Abercrombie & Fitch position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,567 Abercrombie & Fitch shares in Q2 2024, an estimated $322K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Abercrombie & Fitch in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Abercrombie & Fitch position peaked at $3.42M in Q1 2016.
- 435 funds tracked by Wall St. Rank held Abercrombie & Fitch as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.